Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of erlotinib and bevacizumab in never-smokers with stage IIIB/IV non-small cell lung cancer; results posted after compl…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Onartuzumab (MetMAb) plus paclitaxel and platinum versus placebo in squamous non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) [Phase 3]
Phase 3 trial of tinzaparin (low molecular weight heparin) in non-small cell lung cancer has completed. The update does not report trial res…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating AMG 102 in combination with erlotinib in advanced non-small cell lung cancer has completed and results were pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the combination of EGFR-TKIs with chemotherapy as first-line therapy for adv…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial assessing nabilone for attenuation of anorexia and improvements in nutritional status and quality of life in …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating consolidation therapy with fulvestrant and anastrozole in postmenopausal women with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]
The clinical trial TF2 radioimmunotherapy for small cell lung cancer and non-small cell lung cancer has completed Phase 1 and Phase 2 studie…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation [Phase 3]
Phase 3 trial evaluating first-line icotinib with concurrent radiotherapy in EGFR-mutant non-small cell lung cancer; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases [Phase 1]
This Phase 1 trial assessed the maximum tolerated dose of vandetanib when given with whole brain radiotherapy in patients with non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Phase 1]
This Phase I trial update describes two cisplatin-based regimens—vinorelbine plus cisplatin and gemcitabine plus cisplatin—for locally advan…
-
CLINICAL_TRIALS withdrawal · 2016-08-26Clinical Trial Update: Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of auranofin and sirolimus in advanced solid tumors including recurrent non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating ZD6474 (vandetanib) alone or in combination with paclitaxel and carboplat…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. [Phase 2]
This document reports a completed Phase 2 trial evaluating the efficacy and safety of ZD6474 in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474 Phase IIa Dose Finding Multicentre Study [Phase 2]
Genzyme, a Sanofi company, sponsored a completed Phase IIa dose-finding multicentre study of ZD6474 (vandetanib) in non-small cell lung canc…
-
CLINICAL_TRIALS research · 2016-08-25Clinical Trial Update: Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC [Phase 3]
Phase 3 clinical trial evaluating the efficacy, safety, and immunogenicity of CBT124 with EU-sourced Avastin (bevacizumab) in stage 4 non-sm…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study [Phase 3]
A multicenter Phase 3 randomized study comparing whole-brain radiation therapy alone to erlotinib given with WBRT as first-line treatment in…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: ZD6474(Vandetanib) + Alimta Combo Study [Phase 1]
A Phase 1 study evaluating Vandetanib (ZD6474) in combination with Alimta (pemetrexed) for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. [Phase 2]
A Phase 2 trial comparing the efficacy of ZD6474 (vandetanib) and ZD1839 (gefitinib) in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]
Phase 4 trial update of Tarceva (erlotinib) as first- or second-line treatment in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Avastin (bevacizumab) with platinum-based chemotherapy for advanced or recurrent squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy
A registry study evaluating thoracic reirradiation for non-small cell lung cancer using proton beam therapy or intensity-modulated radiation…
-
FDA approval · 2016-08-23FDA Approved: PACLITAXEL PACLITAXEL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved the original application for a generic paclitaxel product, manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmac…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Results from a Phase 1/2 study of MM-121 in combination therapy for advanced non-small cell lung cancer have been posted. The trial, sponsor…